Zhejiang Orient Gene Biotech Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 2,235.856 million compared to CNY 110.363 million a year ago. Operating income was CNY 1,377.376 million compared to CNY 53.542 million a year ago. Net income was CNY 1,186.355 million compared to CNY 43.916 million a year ago. Basic earnings per share from continuing operations was CNY 9.89 compared to CNY 0.37 a year ago.